Role of erythropoietin in cortisol-induced hypertension

Journal of Human Hypertension

Volumn 14, Issue 3, 2000, Pages 195-198

  Kelly, John J ^a,c   Martin, A ^a   Whitworth, J A ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Biology and Environment   (Australia)

^c ST GEORGE HOSPITAL   (Australia)

Author keywords

Cortisol; Erythropoietin; Nitric oxide; Vascular reactivity

Indexed keywords

ERYTHROPOIETIN; HYDROCORTISONE;

ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL;

EID: 0034057764     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000959     Document Type: Article

References (13)

1. Kelly JJ, Mangos G, Williamson PM, Whitworth JA. Cortisol and Hypertension. Clin Exp Pharmacol Physiol 1998; 25: S51-S56.
2. Williamson PM, Kelly JJ, Whitworth JA. Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans. J Hypertens 1996; 14: S37-S41.
3. Tam SH, Kelly JJ, Williamson PM, Whitworth JA. Reflex sympathetic function in cortisol-induced hypertension in humans. Clin Exp Hypertens 1997; 19: 479-493.
4. Macefield VG et al. Muscle sympathetic vasoconstrictor activity in hydrocortisone-induced hypertension in humans. Blood Pressure 1998; 7: 215-222.
5. Kelly JJ et al. The nitric oxide system and cortisol-induced hypertension in humans. Clin Exp Pharmacol Physiol 1998; 25: 945-946.
6. Langenfeld MRW et al. Is endogenous erythropoietin a pathogenetic factor in the development of essential hypertension? Nephrol Dial Transplant 1997; 12: 1155-1160.
7. Heidenreich S, Rahn K-H, Zidek W. Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Kidney Int 1991; 39: 259-265.
8. Vaziri ND et al. Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure. Am J Phvsiol 1996; 271: E113-E122.
9. Lim GB et al. Regulation of erythropoietin gene expression in fetal sheep by glucocorticoids. Endocrinology 1996; 137: 1658-1663.
10. Wang X, Vaziri ND. Erythropoietin depresses nitric oxide synthase expression by human endothelial cells. Hypertension 1999; 33: 894-899.
11. Kang DH, Yoon KI, Han DS. Acute effects of recombinant human erythropoietin on plasma levels of pro-endothelin-1 and endothelin-1 in haemodialysis patients. Nephrol Dial Transplant 1998; 13: 2877-2883.
12. Liefeldt L et al. Transcriptional regulation of endothelin-1 by erythropoietin in endothelin cells. J Cardiovasc Pharmacol 1998; 31: S464-S466.
13. Kelly JJ, Whitworth JA. Endothelin-1 as a mediator in cardiovascular disease. Clin Exper Phamacol Physiol 1999; 26: 158-161.